| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 148 |
| 1 | OXYCODONE | 143 |
| 2 | NICOTINE POLACRILEX | 77 |
| 3 | NICOTINE | 70 |
| 4 | NICOTINE POLACRILEX MINI | 69 |
| 5 | NICOTINE POLARILEX | 69 |
| 6 | BUPRENORPHINE | 65 |
| 7 | ARIPIPRAZOLE | 57 |
| 8 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 57 |
| 9 | ONDANSETRON HYDROCHLORIDE | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRSEVIMAB | 28 | 0.0156 |
| 1 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 148 | 0.0121 |
| 2 | XYLOMETAZOLINE HYDROCHLORIDE | 5 | 0.0088 |
| 3 | BUPROPION HYDROBROMIDE | 5 | 0.0087 |
| 4 | PORACTANT ALFA | 6 | 0.0081 |
| 5 | CARGLUMIC ACID | 5 | 0.0066 |
| 6 | CHLOROTHIAZIDE SODIUM | 6 | 0.0065 |
| 7 | HUMAN RHO(D) IMMUNE GLOBULIN | 5 | 0.0049 |
| 8 | CHLOROTHIAZIDE | 6 | 0.0048 |
| 9 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 57 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Opioid Agonist [EPC] | 159 |
| 1 | Anti-epileptic Agent [EPC] | 92 |
| 2 | Atypical Antipsychotic [EPC] | 92 |
| 3 | Cholinergic Nicotinic Agonist [EPC] | 78 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 74 |
| 5 | Benzodiazepine [EPC] | 71 |
| 6 | Partial Opioid Agonist [EPC] | 65 |
| 7 | Mood Stabilizer [EPC] | 64 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 57 |
| 9 | Corticosteroid [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 28 | 0.0156 |
| 1 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 5 | 0.0066 |
| 2 | Surfactant [EPC] | 6 | 0.0052 |
| 3 | Oxytocic [EPC] | 7 | 0.0023 |
| 4 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 5 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 3 | 0.0015 |
| 6 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 7 | Cholinergic Nicotinic Agonist [EPC] | 78 | 0.0013 |
| 8 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 9 | Progesterone [EPC] | 22 | 0.0009 |